Yoichi Naritomi
Biopharmaceutical and Pharmacokinetic Research Laboratories
Fujisawa Pharmaceutical Co.
Ltd., Kashima
Yodogawa-ku
Japan
Name/email consistency: high
- Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate. Naritomi, Y., Terashita, S., Kagayama, A. Xenobiotica (2004)
- Utility of microtiter plate assays for human cytochrome P450 inhibition studies in drug discovery: application of simple method for detecting quasi-irreversible and irreversible inhibitors. Naritomi, Y., Teramura, Y., Terashita, S., Kagayama, A. Drug Metab. Pharmacokinet. (2004)
- Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Naritomi, Y., Terashita, S., Kagayama, A., Sugiyama, Y. Drug Metab. Dispos. (2003)
- Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Naritomi, Y., Terashita, S., Kimura, S., Suzuki, A., Kagayama, A., Sugiyama, Y. Drug Metab. Dispos. (2001)
